Entry |
|
Name |
Mutation-caused aberrant Abeta to IRE1a-JNK signaling pathway
|
Definition |
APP* -> Abeta -> MAP3K5 -> MAP2K7 -> JNK |
Expanded |
351v1 -> (C16515,C16514) -> 4217 -> 5609 -> (5599,5601,5602) |
Class |
|
Type |
Variant
|
Pathway |
|
Disease |
|
Gene |
351 | APP; amyloid beta precursor protein |
4217 | MAP3K5; mitogen-activated protein kinase kinase kinase 5 |
5609 | MAP2K7; mitogen-activated protein kinase kinase 7 |
5599 | MAPK8; mitogen-activated protein kinase 8 |
5601 | MAPK9; mitogen-activated protein kinase 9 |
5602 | MAPK10; mitogen-activated protein kinase 10 |
|
Variant |
351v1 (APP*) APP mutation
|
Metabolite |
C16515 | Beta-amyloid protein 42 |
C16514 | Beta-amyloid protein 40 |
|
Reference |
|
Authors |
Li JQ, Yu JT, Jiang T, Tan L |
Title |
Endoplasmic reticulum dysfunction in Alzheimer's disease. |
Journal |
|
Reference |
|
Authors |
Song J, Park KA, Lee WT, Lee JE |
Title |
Apoptosis signal regulating kinase 1 (ASK1): potential as a therapeutic target for Alzheimer's disease. |
Journal |
|
LinkDB |
|